Screener
Inhibrx Biosciences, Inc. INBX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Other receivables | 186 | 177 |
| Prepaid expenses and other current assets | 9,498 | 8,435 |
| Total current assets | 171,341 | 132,832 |
| Property and equipment, net | 3,196 | 3,733 |
| Operating right-of-use asset | 5,052 | 5,535 |
| Other non-current assets | 4,378 | 4,378 |
| Total assets | $183,967 | $146,478 |
| Liabilities and stockholders’ equity (deficit) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s PP&E (net)?
- Inhibrx Biosciences, Inc. (INBX) reported PP&E (net) of $3.2M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s PP&E (net) changed year-over-year?
- Inhibrx Biosciences, Inc.'s PP&E (net) decreased by 42.4% year-over-year, from $5.55M to $3.2M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s PP&E (net) has grown at a -23.7% compound annual growth rate (CAGR), from $6.42M to $3.73M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Inhibrx Biosciences, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude